Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Taysha Gene Therapies (TSHA) Prepaid Assets (2022 - 2025)

Historic Prepaid Assets for Taysha Gene Therapies (TSHA) over the last 4 years, with Q3 2025 value amounting to $2.2 million.

  • Taysha Gene Therapies' Prepaid Assets fell 3686.37% to $2.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.2 million, marking a year-over-year decrease of 3686.37%. This contributed to the annual value of $2.6 million for FY2024, which is 2397.24% down from last year.
  • As of Q3 2025, Taysha Gene Therapies' Prepaid Assets stood at $2.2 million, which was down 3686.37% from $3.1 million recorded in Q2 2025.
  • Taysha Gene Therapies' Prepaid Assets' 5-year high stood at $10.6 million during Q2 2022, with a 5-year trough of $2.2 million in Q3 2025.
  • In the last 4 years, Taysha Gene Therapies' Prepaid Assets had a median value of $4.2 million in 2024 and averaged $5.8 million.
  • Its Prepaid Assets has fluctuated over the past 5 years, first crashed by 6370.68% in 2024, then tumbled by 683.34% in 2025.
  • Over the past 4 years, Taysha Gene Therapies' Prepaid Assets (Quarter) stood at $8.5 million in 2022, then plummeted by 59.25% to $3.5 million in 2023, then decreased by 23.97% to $2.6 million in 2024, then fell by 18.41% to $2.2 million in 2025.
  • Its last three reported values are $2.2 million in Q3 2025, $3.1 million for Q2 2025, and $3.7 million during Q1 2025.